tiprankstipranks
Trending News
More News >
Mental Health Technologies Co. Ltd. (JP:9218)
:9218
Japanese Market
Advertisement

Mental Health Technologies Co. Ltd. (9218) AI Stock Analysis

Compare
0 Followers

Top Page

JP:9218

Mental Health Technologies Co. Ltd.

(9218)

Rating:73Outperform
Price Target:
¥940.00
▲(18.69% Upside)
The overall stock score of 73 reflects strong technical momentum and solid financial performance, despite challenges in profitability and valuation concerns. The stock's bullish trend is a significant positive, but the high P/E ratio and lack of dividend yield may deter some investors. Addressing profitability and leverage issues could enhance long-term stability.

Mental Health Technologies Co. Ltd. (9218) vs. iShares MSCI Japan ETF (EWJ)

Mental Health Technologies Co. Ltd. Business Overview & Revenue Model

Company DescriptionMental Health Technologies Co. Ltd. (9218) is a leading provider of innovative digital solutions aimed at enhancing mental health care delivery. The company operates primarily in the healthcare technology sector, focusing on developing software applications and platforms that facilitate mental health assessments, teletherapy, and patient management. Its core products include mobile applications, online therapy platforms, and analytics tools designed to improve patient outcomes and streamline mental health services for providers.
How the Company Makes MoneyMental Health Technologies Co. Ltd. generates revenue through multiple streams, including subscription fees from healthcare providers using its software solutions, licensing of its technology to third-party organizations, and direct-to-consumer offerings. Key revenue streams include monthly or annual subscriptions for access to its teletherapy platforms and analytics tools, which are used by mental health practitioners and institutions. Additionally, the company may engage in partnerships with healthcare organizations, insurance companies, and educational institutions to provide integrated mental health solutions, further enhancing its earnings through collaborative contracts and service agreements.

Mental Health Technologies Co. Ltd. Financial Statement Overview

Summary
Mental Health Technologies Co. Ltd. has demonstrated strong revenue growth and efficient cost management, but faces challenges in profitability and increased leverage. The company's cash flow generation is improving, yet inconsistent free cash flow growth and rising debt levels pose potential risks. Overall, the company is on a growth trajectory but needs to address profitability and leverage concerns to ensure long-term financial stability.
Income Statement
75
Positive
The company has shown significant revenue growth over the years, with a notable increase from 2023 to 2024. However, the net profit margin turned negative in 2024, indicating profitability challenges. The gross profit margin remains healthy, suggesting efficient cost management. EBIT and EBITDA margins have decreased, reflecting increased operational expenses.
Balance Sheet
68
Positive
The balance sheet shows a substantial increase in total assets and equity over the years, indicating growth. However, the debt-to-equity ratio has increased significantly, suggesting higher leverage and potential risk. The equity ratio remains stable, but the rise in debt levels could impact financial stability.
Cash Flow
70
Positive
The company has improved its operating cash flow, indicating better cash generation from operations. However, free cash flow growth is inconsistent, and the free cash flow to net income ratio is affected by the negative net income in 2024. The operating cash flow to net income ratio is strong, reflecting efficient cash management despite profitability issues.
BreakdownTTMDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue5.72B5.13B2.61B2.29B1.45B947.04M
Gross Profit1.96B1.84B1.45B1.43B769.72M451.58M
EBITDA612.52M224.92M559.90M427.19M162.13M-119.87M
Net Income326.85M-29.78M441.37M265.12M161.83M-149.06M
Balance Sheet
Total Assets4.59B4.63B1.73B1.30B663.62M374.45M
Cash, Cash Equivalents and Short-Term Investments1.03B1.12B913.71M659.51M423.50M188.81M
Total Debt2.47B2.57B332.49M183.78M188.52M222.68M
Total Liabilities3.22B3.33B618.32M640.75M416.20M376.76M
Stockholders Equity1.37B1.29B1.12B655.37M247.42M-2.31M
Cash Flow
Free Cash Flow0.00199.15M111.83M325.17M181.38M-120.36M
Operating Cash Flow0.00270.51M177.54M377.49M202.14M-119.72M
Investing Cash Flow0.00-2.15B-90.61M-260.33M-20.79M-642.00K
Financing Cash Flow0.002.08B167.28M118.85M53.33M203.13M

Mental Health Technologies Co. Ltd. Technical Analysis

Technical Analysis Sentiment
Neutral
Last Price792.00
Price Trends
50DMA
723.86
Positive
100DMA
720.86
Positive
200DMA
739.25
Positive
Market Momentum
MACD
26.60
Positive
RSI
52.71
Neutral
STOCH
10.81
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:9218, the sentiment is Neutral. The current price of 792 is below the 20-day moving average (MA) of 808.50, above the 50-day MA of 723.86, and above the 200-day MA of 739.25, indicating a neutral trend. The MACD of 26.60 indicates Positive momentum. The RSI at 52.71 is Neutral, neither overbought nor oversold. The STOCH value of 10.81 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for JP:9218.

Mental Health Technologies Co. Ltd. Peers Comparison

Overall Rating
UnderperformOutperform
Sector (51)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
73
Outperform
¥12.79B12.15
2.41%7.79%38592.95%
73
Outperform
¥8.23B24.94
64.32%289.65%
52
Neutral
¥3.97B
-2.66%-913.85%
51
Neutral
$7.95B-0.40-41.67%2.21%22.29%-1.85%
50
Neutral
¥9.80B105.45
21.39%
45
Neutral
¥15.02B
35.15%16.85%
40
Neutral
¥6.76B
-2.60%-103.03%
* Healthcare Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
JP:9218
Mental Health Technologies Co. Ltd.
792.00
30.00
3.94%
JP:2934
J Frontier Co., Ltd.
1,894.00
522.00
38.05%
JP:3628
Data Horizon Co., Ltd.
532.00
16.00
3.10%
JP:4263
SUSMED,Inc.
893.00
313.00
53.97%
JP:4320
CE Holdings Co., Ltd.
760.00
299.78
65.14%
JP:6034
MRT Inc.
712.00
-307.00
-30.13%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Aug 16, 2025